Literature DB >> 20809427

Human papillomavirus and colorectal cancer: evidences and pitfalls of published literature.

Laura Lorenzon1, Mario Ferri, Emanuela Pilozzi, Maria Rosaria Torrisi, Vincenzo Ziparo, Deborah French.   

Abstract

PURPOSE: The aim of this study is to review published literature regarding a possible role of human papillomavirus (HPV) infection in colorectal cancer in order to understand if HPV infection plays an active role in colorectal carcinogenesis and to highlight evidences and pitfalls of published studies.
METHODS: We reviewed literature by searching PubMed, Ovid, and the Cochrane databases for published series investigating HPV and colorectal cancer from 1988 to date.
RESULTS: Twenty-one studies investigating a possible correlation between HPV infection and colon cancer have been published. We reviewed 15 case-control studies and six studies investigating a possible role for HPV virus in colorectal carcinogenesis. HPV was detected in the majority of reported series with a significant difference in HPV infection between tumors and disease-free controls or tumor-adjacent tissue; the HPV mean detection rate within carcinomas was 41.7%, comparing to a mean detection rate of 32.8% in adjacent colic mucosae, and 5.8% in disease-free controls (Chi-square test, p = 0.001). The correlation between HPV infection and c-myc amplification, k-ras mutation, and p53 polymorphism or mutations has been investigated; however, the possible role of HPV in colorectal carcinogenesis was not defined.
CONCLUSIONS: HPV has been detected in the majority of reported series, but published literature lacks in definitive data regarding standard methods of investigation and stratification of groups and population. These data encourage further studies with the aim to investigate the presence of the virus in larger series, its possible role in oncogenesis, the integration in host genome, the expression of viral oncoproteins, the mutations in HPV positive cancers and routes of colon infection (hematologic/lymphatic spreading or perineal diffusion).

Entities:  

Mesh:

Year:  2010        PMID: 20809427     DOI: 10.1007/s00384-010-1049-8

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  29 in total

Review 1.  Papillomavirus genome structure, expression, and post-transcriptional regulation.

Authors:  Zhi-Ming Zheng; Carl C Baker
Journal:  Front Biosci       Date:  2006-09-01

2.  Human papillomavirus type-related DNA and c-myc oncogene alterations in colon cancer cell lines.

Authors:  J Y Cheng; C L Meng; C F Chao; S D Gau; J C Lin
Journal:  Dis Colon Rectum       Date:  1991-06       Impact factor: 4.585

3.  Colorectal papillomavirus infection in patients with colorectal cancer.

Authors:  Sohrab Bodaghi; Koji Yamanegi; Shu-Yuan Xiao; Maria Da Costa; Joel M Palefsky; Zhi-Ming Zheng
Journal:  Clin Cancer Res       Date:  2005-04-15       Impact factor: 12.531

4.  Physical status of the E2 human papilloma virus 16 viral gene in cervical preneoplastic and neoplastic lesions.

Authors:  S A Tonon; M A Picconi; P D Bos; J B Zinovich; J Galuppo; L V Alonio; A R Teyssie
Journal:  J Clin Virol       Date:  2001-05       Impact factor: 3.168

5.  Evidence for an association of human papillomavirus infection and colorectal cancer.

Authors:  D C Damin; M B Caetano; M A Rosito; G Schwartsmann; A S Damin; A P Frazzon; R D Ruppenthal; C O P Alexandre
Journal:  Eur J Surg Oncol       Date:  2007-02-22       Impact factor: 4.424

6.  Analysis of adenocarcinoma of the colon and rectum: detection of human papillomavirus (HPV) DNA by polymerase chain reaction.

Authors:  L O Pérez; M C Abba; R M Laguens; C D Golijow
Journal:  Colorectal Dis       Date:  2005-09       Impact factor: 3.788

7.  Investigation of human papillomavirus DNA in colorectal carcinomas and adenomas.

Authors:  Dilek Yavuzer; Nimet Karadayi; Taflan Salepci; Huseyin Baloglu; Resat Dabak; Oya Uygur Bayramicli
Journal:  Med Oncol       Date:  2010-01-16       Impact factor: 3.064

8.  Detection of human papillomavirus DNA by polymerase chain reaction and southern blot hybridization in colorectal cancer patients.

Authors:  T Salepci; H Yazici; F Dane; E Topuz; N Dalay; H Onat; F Aykan; M Seker; A Aydiner
Journal:  J BUON       Date:  2009 Jul-Sep       Impact factor: 2.533

9.  Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina.

Authors:  Luis Orlando Pérez; Martin Carlos Abba; Fernando Noel Dulout; Carlos Daniel Golijow
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

10.  Coexistence of K-ras mutations and HPV infection in colon cancer.

Authors:  Nur Buyru; Ayda Tezol; Nejat Dalay
Journal:  BMC Cancer       Date:  2006-05-04       Impact factor: 4.430

View more
  12 in total

1.  Tumor-based case-control studies of infection and cancer: muddling the when and where of molecular epidemiology.

Authors:  Eric A Engels; Sholom Wacholder; Hormuzd A Katki; Anil K Chaturvedi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-25       Impact factor: 4.254

2.  No association between antibodies to sexually transmitted infections and colorectal hyperplastic polyps in men: Minnesota Cancer Prevention Research Unit Polyp Study.

Authors:  Andrea N Burnett-Hartman; Polly A Newcomb; Stephen M Schwartz; Roberd M Bostick; Michael Pawlita; Tim Waterboer; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-26       Impact factor: 4.254

3.  Human papillomavirus does not have a causal role in colorectal carcinogenesis.

Authors:  Laura Lorenzon; Francesca Mazzetta; Emanuela Pilozzi; Giordana Uggeri; Maria Rosaria Torrisi; Mario Ferri; Vincenzo Ziparo; Deborah French
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

4.  Interpretation of P16 expression as a marker of HPV in colorectal cancer.

Authors:  Fatma S Hafez; Ghada R Meckawy; Mohamed Alorabi; Marwa M Shakweer
Journal:  Histol Histopathol       Date:  2022-02-18       Impact factor: 2.303

5.  Human papillomavirus DNA is rarely detected in colorectal carcinomas and not associated with microsatellite instability: the Seattle colon cancer family registry.

Authors:  Andrea N Burnett-Hartman; Qinghua Feng; Viorica Popov; Anisha Kalidindi; Polly A Newcomb
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-18       Impact factor: 4.254

6.  Co-presence of Epstein-Barr virus and high-risk human papillomaviruses in Syrian colorectal cancer samples.

Authors:  Mohammed I Malki; Ishita Gupta; Queenie Fernandes; Tahar Aboulkassim; Amber Yasmeen; Semir Vranic; Ala-Eddin Al Moustafa; Hamda A Al-Thawadi
Journal:  Hum Vaccin Immunother       Date:  2020-03-18       Impact factor: 3.452

7.  High Prevalence of Human Papillomavirus in Colorectal Cancer in Hispanics: A Case-Control Study.

Authors:  Raul D Bernabe-Dones; Maria Gonzalez-Pons; Alejandro Villar-Prados; Mercedes Lacourt-Ventura; Heriberto Rodríguez-Arroyo; Sharon Fonseca-Williams; Francisco E Velazquez; Yaritza Diaz-Algorri; Sofia M Lopez-Diaz; Nayra Rodríguez; Yasuhiro Yamamura; Marcia Cruz-Correa
Journal:  Gastroenterol Res Pract       Date:  2016-01-19       Impact factor: 2.260

8.  Detection of Human papillomavirus and the role of p16INK4a in colorectal carcinomas.

Authors:  Larisse Silva Dalla Libera; Thalita de Siqueira; Igor Lopes Santos; Jéssica Enocencio Porto Ramos; Amanda Xavier Milhomen; Rita de Cassia Gonçalves de Alencar; Silvia Helena Rabelo Santos; Megmar Aparecida Dos Santos Carneiro; Rosane Ribeiro Figueiredo Alves; Vera Aparecida Saddi
Journal:  PLoS One       Date:  2020-06-25       Impact factor: 3.240

9.  Human papillomavirus (HPV) 16 infection is not detected in rectal carcinoma.

Authors:  Sandra F Martins; Vânia Mariano; Mesquita Rodrigues; Adhemar Longatto-Filho
Journal:  Infect Agent Cancer       Date:  2020-03-05       Impact factor: 2.965

Review 10.  Human papillomavirus and gastrointestinal cancer: A review.

Authors:  Dania Bucchi; Fabrizio Stracci; Nicola Buonora; Giuseppe Masanotti
Journal:  World J Gastroenterol       Date:  2016-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.